Ru

Biomedical and Healthcare Engineering

Biomedical and healthcare engineering is one of the priority research areas at TPU within the Priority 2030 federal program. The Healthcare Engineering strategic project is aimed at developing the scientific and technical backgrounds in the healthcare sector, designing the training models and improving the efficiency of engineering solutions in high-tech areas of medicine.

The goal of the strategic project is to provide research leadership, develop sovereign technologies, new training models and translate them into clinical practice.   

Project Areas:

  • Diagostics. The design, development, testing and translation of advanced diagnostic radiopharmaceuticals, hybrid imaging systems, positron emission and single photon computed tomography facilities, smart data processing systems, clinical decision support systems, diagnostics and monitoring systems incl. instant diagnostic systems.

  • Therapy. The design, development, testing and translation of treatment and theranostic radiopharmaceuticals, methods and techniques to improve the quality and effectiveness of X-ray therapy, hardware and software and X-ray facilities, the development of binary technology based on the TPU unique research facilities.

  • Rehabilitation. The design, development, testing and translation of customizable implants, hardware and software for the neurorehabilitation of patients with circulatory system disorders, health technologies for the improvement of life quality and activity after diseases.

TPU R&D projects in biomedical and healthcare engineering:

Dr. Elena Stasyuk

Dr. Elena Stasyuk

Senior Research Fellow, Nuclear Reactor Laboratory No. 31

  • Radiopharmaceuticals based on nano-sized aluminum, glucose compounds and other Tc99m-labeled molecules for accurate diagnostics of oncological diseases.
Scientist's page
Prof. Viktor Pavlovsky

Prof. Viktor Pavlovsky

Kizhner Research Center, School of Advanced Manufacturing Technologies

  • Synthesis, biological evaluation and molecular modeling of azacrown ether.
  • Synthesis, affinity to benzodiazepine receptors, and pharmacological properties of 3-acyloxy-5-aryl-7-brom-1,2-dihydro-3H-1,4-enzodiazepines-2- one derivatives.
Scientist's page
Prof. Viktor Filimonov

Prof. Viktor Filimonov

Kizhner Research Center, School of Advanced Manufacturing Technologies

Scientist's page
Prof. Elena Krasnokutskaya

Prof. Elena Krasnokutskaya

Kizhner Research Center, School of Advanced Manufacturing Technologies

Scientist's page
Prof. Svetlana Buyakova

Prof. Svetlana Buyakova

Materials Science Department, School of Advanced Manufacturing Technologies

  • Porous ceramic osteoconductive materials for the osseous tissue replacement.
Scientist's page
Prof. Sergey Panin

Prof. Sergey Panin

Materials Science Department, School of Advanced Manufacturing Technologies

  • The development of design fundamentals incl. feedstocks, tribotesting, biocompatible wear-resistant polymer-polymer coupling based on thermoplastic matrixes of ultrahigh molecular weight polyethylene and polyetheretherketone to develop customizing joint implants using the additive technologies.
Scientist's page
Dr. Vladimir Tolmachev

Dr. Vladimir Tolmachev

Director of Oncotheranostics Research Center

  • The development and preclinical evaluation of radiolabeled biologically active compounds (antibodies, polysaccharides, proteins, peptides and small molecules) for biomedicine. The pioneering studies of framework engineering proteins in a radionuclide imaging and medicine are of prime importance:
    • Labeling techniques using the following:
    • positron-emitting radionuclide 18F;
    • long-lived and unconventional positron-emitting radionuclides (44Sc, 68Ga; 55Co,64Cu, 110mIn, 76Br, 124I, 89Zr);
    • single-photon emitters (111In, 123I, 99mTc);
    • therapeutic radionuclides (131I; 114mIn, 90Y, 177Lu; 186Re, 188Re; 211At).
  • Techniques of radionuclide production techniques for biomedicine:
    • manufacturing of unconventional positron emitters 76Br, 110mIn, 68Ga, 66Ga, 83Sr, 124I, 61Cu, 72As, 45Ti, 89Zr, 86Y, 52Fe and 52Fe / 52Mn; 134Ce / 134La;
    • manufacturing of 114m / 114In и 211At for radionuclide therapy.
  • The molecular design and characterization of in vitro radiolabeled compounds.
  • Pre-targeting techniques based on PNA-PNA interaction and the Diels-Alder reaction.
  • Pharmacokinetic studies of labeled compounds with PET.
Scientist's page
Prof. Roman Surmenev

Prof. Roman Surmenev

Director of the Material Physics and Composite Materials Research Center

  • Piezo- and magnetic-electric materials, biomedical composites.
  • Core-shell nanoparticles for theranostics.
  • Biopolymer-based piezonanogenerators, composite materials based on piezopolymers with ceramic and magnet nanoparticles.
  • The additive printing of piezopolymer, ceramic materials and composites.
  • The development, production and testing of piezopolymer biomedical models.
Scientist's page
Prof. Mekhman Yusubov

Prof. Mekhman Yusubov

Chief Research Fellow, Research School of Chemistry and Applied Biomedical Sciences

Scientist's page
Dr. Antonio Di Martino

Dr. Antonio Di Martino

Research School of Chemistry and Applied Biomedical Sciences

Scientist's page
Prof. Alexey Pestryakov

Prof. Alexey Pestryakov

Research School of Chemistry and Applied Biomedical Sciences

Scientist's page
Prof. Andrey Khlebnikov

Prof. Andrey Khlebnikov

Kizhner Research Center, School of Advanced Manufacturing Technologies

Scientist's page
Dr. Maria Larkina

Dr. Maria Larkina

Senior Research Fellow, Oncotheranostics Research Center, Research School of Chemistry and Applied Biomedical Sciences

  • Research of targeted radionuclide agents for molecular diagnostics of malignant tumors.
  • In vitro and in vivo studies of radiopharmaceuticals, the development and research of radiosensitizing and radioprotective compounds, the evaluation of biological impacts on human cells and in vivo models, the study of biocompatibility of advanced materials, nanoparticles and 3D scaffolds, studies of cytotoxicity and bioactivity of new chemical compounds, candidate compounds and drugs in tumor and normal cells.
Scientist's page
Prof. Galina Barysheva

Prof. Galina Barysheva

School of Engineering Entrepreneurship

Scientist's page
Prof. Oleg Khasanov

Prof. Oleg Khasanov

Materials Science Department, School of Advanced Manufacturing Technologies

Scientist's page
Prof. Evgenia Sheremet

Prof. Evgenia Sheremet

Research School of Chemistry and Applied Biomedical Sciences

Scientist's page
Prof. Evgenia Sukhikh

Prof. Evgenia Sukhikh

Director of Research Technological Reference Center of Ionizing Radiation in Radiology, Radiation Therapy and Nuclear Medicine

Scientist's page
Dr. Maria Surmeneva

Dr. Maria Surmeneva

Material Physics and Composite Materials Research Center

Scientist's page
Dr. Sergey Tverdokhlebov

Dr. Sergey Tverdokhlebov

Associate Professor, Weinberg Research Center

  • Biostable and biodegradable polymer implants.
  • Bioactive coating on implants used for the osteosynthesis and coating equipment.
  • Hybrid coating materials for coronary stents for the atherosclerosis treatment and restenosis prevention.
  • Microdevices for implants and living systems.
Scientist's page
Dr. Evgeny Nesterov

Dr. Evgeny Nesterov

Head of Nuclear Reactor Laboratory No 31

Scientist's page